Search results
VT Symposium 2026
Start date:
Oct 10, 2026
End date:
Oct 09, 2026
Event
Added:
1 month ago
HRS Congress 2026 — In this Arrhythmia Academy expert interview, Brad Wilson, Director of Medical Device Partnerships at Radcliffe and Arrhythmia Academy, speaks with Dr. Pasquale Santangeli (Cleveland Clinic, Ohio, USA) about six-month outcomes from the Sphere-9 VT early feasibility study.They review the Affera Sphere-9 lattice tip catheter and mapping-ablation system, a dual-energy, large…
View more
Added:
1 month ago
EHRA 2026 — Dr Ioanna Koniari (University Hospital of Patras, Rio-Patras, Greece) joins us for a forward-looking discussion on the expanding role of pulsed field ablation beyond its established indications, with a focus on ventricular tachycardia and the frontier applications that are beginning to redefine the boundaries of PFA in clinical practice.As operator experience with PFA deepens and…
View more
Added:
1 year ago
EHRA 2025 - We are joined onsite at EHRA Congress 2025 by Prof Pier Lambiase to discuss the latest developments in ventricular tachycardia substrate identification from the EHRA Ablation Summit 2025.Interview Questions:What are the key challenges or limitations that still exist in accurately identifying VT substrates?What are the most significant recent advancements in techniques or technologies…
View more
Added:
1 month ago
EHRA Congress 2026 — Dr Francesco Santoro (University of Foggia, Foggia, IT) joins us to explore how electrophysiologists can approach risk assessment and decision-making when considering catheter ablation in high-risk ventricular tachycardia patients — a population where the potential benefits of ablation must be carefully weighed against procedural complexity and patient frailty.Interview…
View more
Added:
1 month ago
EHRA 2026 — Dr Francesco Santoro joins us to discuss findings from his meta-analysis of randomised controlled trials comparing catheter ablation with anti-arrhythmic drug therapy in patients with ventricular tachycardia and ischaemic heart disease.This meta-analysis pooled data from four RCTs enrolling 947 patients with ischaemic heart disease and ICD implantation, randomised to either catheter…
View more
Added:
2 weeks ago
Dr Usha Tedrow (Brigham and Women's Hospital, Boston, MA, US) discusses contemporary approaches to VT ablation in patients with complex and high-risk substrates, from preprocedural planning and mapping strategy through to long-term management.Interview Questions:How has the approach to VT ablation in high-risk substrates evolved over recent years, and what factors define a patient as high-risk…
View more
Added:
1 month ago
EHRA 2026 — Prof Pier Lambiase (University College London, UK) joins us to examine the evolving landscape of VT mapping, exploring how advances in identifying arrhythmia drivers and delineating conduction channels are reshaping ablation strategy and outcomes in complex ventricular arrhythmia.From the limitations of conventional substrate mapping to the growing role of high-density mapping systems…
View more
Added:
3 months ago
Dr Dhanunjaya Lakkireddy (Kansas City Heart Rhythm Institute, Kansas City, US) and Dr Pasquale Santangeli (Cleveland Clinic, Cleveland, OH, US) discuss evidence-based strategies for preventing complications during complex atrial fibrillation and ventricular tachycardia ablation procedures.This expert discussion focuses on safety considerations in high-risk electrophysiology procedures, comparing…
View more
Added:
1 month ago